Clinical trial / 2020
A daily cocoa beverage improved 6-minute walk distance at 2.5 hours post-consumption in older adults with peripheral artery disease.
In a 6-month trial, 44 participants with peripheral artery disease were randomized to consume a daily cocoa beverage (15 g cocoa, 75 mg epicatechin) or a placebo. Adjusting for smoking, race, and BMI, cocoa improved 6-minute walk distance by 42.6 m (90% CI, +22.2 to +∞; P=0.005) at 2.5 hours after a final beverage, and by 18.0 m (90% CI, -1.7 to +∞; P=0.12) at 24 hours post-beverage compared to placebo. Calf muscle biopsies showed cocoa improved mitochondrial cytochrome c oxidase activity (P=0.013), increased capillary density (P=0.014), improved perfusion (P=0.098), and reduced central nuclei (P=0.033).
- Study type
- Phase II double-blind randomized placebo-controlled trial
- Who was studied
- 44 older participants with peripheral artery disease (mean age 72.3 years)
- What was measured
- 6-month change in 6-minute walk distance at 2.5 and 24 hours post-beverage
THE PAPER
Cocoa to Improve Walking Performance in Older People With Peripheral Artery Disease: The COCOA-PAD Pilot Randomized Clinical Trial.
McDermott MM, Criqui MH, Domanchuk K, Ferrucci L, Guralnik JM, Kibbe MR, Kosmac K, Kramer CM, Leeuwenburgh C, Li L, Lloyd-Jones D, Peterson CA, Polonsky TS, Stein JH, Sufit R, Van Horn L, Villarreal F, Zhang D, Zhao L, Tian L. Circ Res, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.